L87.2

Clinical Causes: Idiopathic: Sometimes the exact cause isn't clear, and EPS occurs without an associated condition. Connective tissue diseases: Conditions such as pseudoxanthoma elasticum or Ehlers-Danlos syndrome have been linked to EPS. Genetic predisposition: Some cases may have a hereditary component, although this is not well understood. Drug reactions: Certain medications, like penicillamine, have been associated with the development of EPS. Other factors: Chronic sun exposure or skin trauma might contribute in certain cases.

Key Symptoms: Multiple uniform, firm, skin-colored or pink bumps, usually less than 1 cm in diameter. Lesions often have a characteristic keratotic or verrucous surface. Lesions may develop a circular, serpiginous (snake-like), or arcuate pattern. Commonly found on the neck, face, forearms, and hands. Sometimes lesions can be itchy or slightly tender.

Diagnosis Path: Diagnosis of EPS involves a clinical examination of the skin lesions, noting their distinctive appearance and pattern. A skin biopsy is typically performed to confirm the diagnosis, revealing abnormal elastic fibers within the skin. Special staining techniques, such as Verhoeff-Van Gieson stain, highlight elastic tissue changes. Additional tests may be conducted to evaluate for underlying connective tissue disorders if suspected.

Treatment Protocols: Topical therapies: Corticosteroids or retinoids to reduce inflammation and lesion development. Procedural removal: Cryotherapy or laser treatments to eliminate lesions, especially if they are bothersome or widespread. Addressing underlying conditions: Managing associated connective tissue diseases can sometimes improve skin symptoms. Monitoring: As EPS can sometimes resolve on its own or persist without progression, regular follow-up is advised.